SynthesisDaru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences2025

Efficacy of dostarlimab in recurrent or advanced mismatch Repair-Deficient endometrial Cancer as a Single-Agent therapy: A systematic review and Meta-Analysis.

Ramazan Rezaei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.